Everything You Need to Know About Gout in One Brochure

Hello Gout Education,

The Gout Education Society is committed to raising awareness of gout—the most common form of inflammatory arthritis and how to manage it for the long term. The Society offers a variety of free, unbiased resources at GoutEducation.org to help you learn more about gout and treatment options.

This month, the Society is pleased to introduce its latest resource, an updated brochure with everything you need to know about gout and uric acid. The 15-page brochure dives into all the needed information regarding the disease who my need after being diagnosed.

Education on gout is the primary line of defense when it comes to managing the disease. With that in mind, the Go for Six with Gout brochure was developed to cover all the basic questions one may have:

• What is gout and what is the role of uric acid in the disease?
• How do I manage my uric acid levels and what are my treatment options?
• Why am I having gout flares?
• What diet & lifestyle modifications should I make?
• Are there any other health conditions to watch out for alongside gout?
• How should I talk to my doctor about managing the disease?

You can access the updated brochure on our website and order a paper copy, free of charge, to be delivered to you.

Have any questions or need resources? Email us: [email protected].

Featured Cartoon

Trick your gout this Halloween by treating yourself to proper care. Get your uric acid levels checked every six months and aim for below 6.0 mg/dL.



New Blog: How Long Does Gout Last

Some people think that gout is a disease that comes and goes; however, this is incorrect. Gout is a lifelong disease that requires ongoing management. The Gout Education Society has developed a new blog post to discuss the basics about gout flares and treatment options.

Clinical Trial Opportunity: Have Hyperuricemia?

LG Chem is looking for 350 participants across several different regions to try out Tigulixostat, a medication designed to stop the enzyme that metabolizes purines. Purines are the compounds that become uric acid. When built up over time, this can cause hyperuricemia, which is the root cause of gout.

Tigulixostat is classified as a xanthine oxidase inhibitor, similar to allopurinol or febuxostat. The Phase 3 clinical trial intends to test the drug’s effectiveness for six months in people with hyperuricemia, versus those who are given a placebo.

Find out here if you are eligible to participate

Clinical Trial Seeks People with an Acute Gout Attack

Olatec Therapeutics is seeking participants for its Phase 2/3 clinical trial in patients with an acute gout flare. The objective of the clinical trial is to test an oral anti-inflammatory, called dapansutrile, which is an investigational drug not yet approved by FDA. The trial will assess the effectiveness of dapansutrile in treating inflammatory pain over 8 days in people with gout who are experiencing an acute gout attack versus those who are given a placebo. Rescue treatment is offered if pain remains intolerable while on study. 

The trial is seeking participants located throughout the USA and in Europe. 

To find out if you're eligible please visit clinicaltrials.gov and/or contact [email protected]

Clinical Trial Seeks People Around Houston

Advanced Rheumatology of Houston is seeking participants with diagnosed gout for research on treatment options for the disease. Participants must be willing to commit time for study visits at the practice's clinic in The Woodlands, Texas.

To find out if you are eligible or to sign up please contact Advanced Rheumatology of Houston at (936) 681 4882

Stay up to date on the most recent gout news